Literature DB >> 11743057

Association of BMI with the beta3-adrenergic receptor gene polymorphism in Japanese: meta-analysis.

N Kurokawa1, K Nakai, S Kameo, Z M Liu, H Satoh.   

Abstract

OBJECTIVE: To assess the effect of the Trp64Arg polymorphism in the beta3-adrenergic receptor gene (ADRB3) on body mass index (BMI) in the Japanese population. RESEARCH METHODS AND PROCEDURES: We selected studies that evaluated the association between BMI and ADRB3 polymorphism among Japanese, using MEDLINE and PubMed. After data collection, an extension of ANOVA was performed to assess the differences according to the genotype.
RESULTS: In a total of 35 subgroups including 2316 subjects with the Trp64Arg variant and 4266 subjects without this variant, the weighted mean difference in BMI was 0.26 kg/m(2) (95% confidence interval: 0.18 to 0.42; p < 0.01), indicating that variant carriers exhibited higher BMI than did normal homozygous subjects. DISCUSSION: Although it is known that the allele frequency of the ADRB3 polymorphism differs among races, this study focuses on the Japanese population, which has a high allele frequency of ADRB3 polymorphism. We assumed that statistical errors would be prevented due to the sufficient number of subjects. In conclusion, the results support the hypothesis that ADRB3 gene polymorphism is associated with BMI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11743057     DOI: 10.1038/oby.2001.102

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  21 in total

1.  Higher cardiorespiratory fitness attenuates the risk of atherosclerosis associated with ADRB3 Trp64Arg polymorphism.

Authors:  Motoyuki Iemitsu; Shumpei Fujie; Haruka Murakami; Kiyoshi Sanada; Hiroshi Kawano; Yuko Gando; Ryoko Kawakami; Noriko Tanaka; Motohiko Miyachi
Journal:  Eur J Appl Physiol       Date:  2014-03-23       Impact factor: 3.078

Review 2.  Recent progress in the genetics of common obesity.

Authors:  Ruth J F Loos
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

3.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

Review 4.  From obesity genetics to the future of personalized obesity therapy.

Authors:  Julia S El-Sayed Moustafa; Philippe Froguel
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

5.  Beta-3-adrenergic receptor Trp64Arg polymorphism: does it modulate the relationship between exercise and percentage of body fat in young adult Japanese males?

Authors:  Hiroshi Nakashima; Kazuyuki Omae; Tetsuo Nomiyama; Yuko Yamano; Toru Takebayashi; Yutaka Sakurai
Journal:  Environ Health Prev Med       Date:  2013-01-06       Impact factor: 3.674

6.  Effect of the β3-adrenergic receptor gene polymorphism Trp64Arg on BMI reduction associated with an exercise-based intervention program in Japanese middle-aged males.

Authors:  Aya Tahara; Yoneatsu Osaki; Takuji Kishimoto
Journal:  Environ Health Prev Med       Date:  2010-05-26       Impact factor: 3.674

7.  Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Authors:  Kazuko Masuo
Journal:  Int J Hypertens       Date:  2010-10-21       Impact factor: 2.420

Review 8.  The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.

Authors:  Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-09       Impact factor: 3.000

9.  ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Authors:  Maha Daghestani; Mazin Daghestani; Mamoon Daghistani; Abdelmoneim Eldali; Zeinab K Hassan; Maha H Elamin; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

10.  The association between hyperuricemia and the Trp64Arg polymorphism of the beta-3 adrenergic receptor.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2007-01-16       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.